🇫🇷 IMDEVIMAB in France

ANSM authorised IMDEVIMAB on 12 November 2021

Marketing authorisation

ANSM — authorised 12 November 2021

  • Marketing authorisation holder: ROCHE REGISTRATION GMBH
  • Status: approved

IMDEVIMAB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in France

Frequently asked questions

Is IMDEVIMAB approved in France?

Yes. ANSM authorised it on 12 November 2021.

Who is the marketing authorisation holder for IMDEVIMAB in France?

ROCHE REGISTRATION GMBH holds the French marketing authorisation.